Novel Laboratories, Inc. d.b.a Lupin Somerset: Drug Recall

Recall #D-0628-2024 · 07/02/2024

Class III: Low Risk

Recall Details

Recall Number
D-0628-2024
Classification
Class III
Product Type
Drug
Recalling Firm
Novel Laboratories, Inc. d.b.a Lupin Somerset
Status
Terminated
Date Initiated
07/02/2024
Location
Somerset, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,200 cartons

Reason for Recall

Defective container: potential for non-sealed pouches which can lead to product leakage.

Product Description

PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26.

Distribution Pattern

Nationwide in the US.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.